Indinavir: uses, dosing, side effects & brands
Indinavir is a medicine sold in the U.S. under one brand. Below: what the FDA label says, every product that contains it, what the pills look like, and its recall record.
Key facts
- Available as
- Capsule
- Sold as
- Crixivan
- Prescription?
- Prescription only
- Generic available?
- Not in our catalog
Every indinavir product we track (1)
Same active ingredient — different manufacturer, form, price and FDA recall record. That last one is what our independent score measures.
Only one: Crixivan.
What indinavir pills look like
Imprint codes, colour and shape from the FDA’s labelling data. Match the imprint on your pill — or search any imprint.
| Imprint | Strength | Colour | Shape | Maker |
|---|---|---|---|---|
| CRIXIVAN;400;mg | 400 mg | white | capsule | — |
| CRIXIVAN;400;mg | 400 mg | white | capsule | — |
| CRIXIVAN;400;mg | 400 mg | white | capsule | — |
Indinavir and breastfeeding
From LactMed, the US National Library of Medicine’s Drugs and Lactation Database — quoted, not rewritten.
Full LactMed record for indinavir: levels in milk, effects in breastfed infants, and the drugs it would consider insteadIndinavir is no longer marketed in the US. Published experience with indinavir during breastfeeding is limited, but some infants may achieve high levels of the drug in breastmilk. Indinavir is not a recommended agent during breastfeeding. Achieving and maintaining viral suppression with antiretroviral therapy decreases breastfeeding transmission risk to less than 1%, but not zero. Individuals with HIV who are on antiretroviral therapy with a sustained undetectable viral load and who choose to breastfeed should be supported in this decision. If a viral load is not suppressed, banked pasteurized donor milk or formula is recommended.
National Institute of Child Health and Human Development, record revised July 15, 2024. LactMed states its information is not a substitute for professional judgement.
What people report to the FDA about indinavir
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 345 reports naming indinavir, and the FDA flagged 97% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- lipodystrophy acquired156 reports
- eyelid ptosis153 reports
- diplopia151 reports
- mitochondrial toxicity151 reports
- dysphagia78 reports
- progressive external ophthalmoplegia75 reports
- ophthalmoplegia53 reports
- vomiting44 reports
Read these as a signal, not a rate. A report does not mean indinavir caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label section above.
Source: openFDA drug/event (FAERS), retrieved July 25, 2026.
Related calculators
Frequently asked questions
Can you take indinavir with other medicines?
It depends on the medicine. We check it against the FDA labels rather than guessing: our interaction checker searches each drug's own label for the other and quotes what it says, naming the section it came from. Run indinavir against whatever else you take — and remember that a label not naming a drug is not the same as that combination being safe.
What forms does indinavir come in?
Across the brands we track, indinavir is currently marketed as capsule, per the FDA's National Drug Code Directory. Each form is dosed differently — follow the label for the exact product you were prescribed.
Is there a generic indinavir?
We do not currently list a generic-labelled indinavir product. That does not always mean none exists — it means none appears under a generic name in the FDA data we track. Ask your pharmacist.
Cite this page
- APA
- pharmaranks. (2026, July 24). Indinavir: uses, dosing, side effects & brands. https://pharmaranks.com/drugs/indinavir
- MLA
- “Indinavir: uses, dosing, side effects & brands.” pharmaranks, 24 July 2026, https://pharmaranks.com/drugs/indinavir.
We summarise public FDA and NIH sources — for a clinical claim, cite the primary source we link to as well.
Sources: FDA openFDA drug label, National Drug Code Directory, and Enforcement (recall) database. This page reproduces public FDA data and is not medical advice. Dosing is set by your prescriber.
Read the full FDA label for indinavir on DailyMed (NIH) ↗.